Life Molecular Imaging SA.: Clinical Trials

4 trials sponsored by Life Molecular Imaging SA., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow Life Molecular Imaging SA.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
Alzheimer Disease
UnknownXuanwu Hospital, Beijing602021-11-202022-04-13
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
[18F]PI-2620 - Mild Traumatic Brain Injury
Phase 1TerminatedLife Molecular Imaging SA.182021-06-072024-05-14
Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity
[18F]-PI2620 - Alzheimer Disease, Progressive Supranuclear Palsy
Phase 1CompletedLife Molecular Imaging GmbH102020-11-122026-10-26
18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis
18F-GP1 - Thrombosis Cardiac, Aortic Valve Disease
CompletedUniversity of Edinburgh532019-10-222024-09-19

Conditions studied

Alzheimer Disease (2)  ·  Aortic Valve Disease (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Pick Disease of the Brain (1)  ·  Supranuclear Palsy, Progressive (1)

Interventions

((18)F)PI-2620 (2)

Countries

China (1)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Andrew Stephens, MD, PhD (1)  ·  Biao Chen, Doctor (1)  ·  David E Newby, MD (1)

Results publications

PMID 35033495